TTRX vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 05, 2026

TTRX

35.1
AI Score
VS
JBIO Wins

JBIO

55.4
AI Score

Investment Advisor Scores

TTRX

35score
Recommendation
AVOID NEW MONEY

JBIO

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric TTRX JBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 35.1/100 55.4/100 JBIO
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD JBIO

Relative Price Performance (Last 90 Days)

TTRX 1M: +22.0% · 3M: +26.5% JBIO 1M: -28.6% · 3M: -36.9%

Current Technical Phase

TTRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $12.29

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 25

RSI (14): 24.9 · Price: $14.17

Fundamentals Snapshot

Metric TTRX JBIO
Market Cap — —
Forward P/E -29.6 -5.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.26 -1.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.